Showing results (61-70 of 206) with videos related to
Sort By:
Pageof 21
Clinical and Experimental Dermatology|October 24, 2000
Management of malignant melanoma: new developments in immune and gene therapyA Schneeberger, M Goos, G Stingl, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 3, 1999
The tumorigenicity of IL-2 gene-transfected murine M-3D melanoma cells is determined by the magnitude and quality of the host defense reaction: NK cells play a major roleA Schneeberger, F Koszik, W Schmidt, et al.The Journal of Experimental Medicine|March 17, 1997
A skin homing molecule defines the langerhans cell progenitor in human peripheral bloodD Strunk, C Egger, G Leitner, et al.The Journal of Investigative Dermatology|August 1, 1977
In situ identification of lymphoreticular cells in benign and malignant infiltrates by membrane receptor sitesG Stingl, K Wolff, E Diem, et al.The Journal of Investigative Dermatology|February 1, 1986
Leu-3/T4 expression on epidermal Langerhans cells in normal and diseased skinV Groh, M Tani, A Harrer, et al.The Journal of Investigative Dermatology|May 1, 1980
The functional role of Langerhans cellsG Stingl, S I Katz, I Green, et al.Journal of the American Academy of Dermatology|March 1, 1987
Azathioprine in the treatment of pemphigus vulgaris. A long-term follow-upW Aberer, E C Wolff-Schreiner, G Stingl, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1992
Demonstration of a CD3+ lymphocyte subset in the epidermis of athymic nude mice. Evidence for T cell receptor diversityE Payer, R Strohal, R Kutil, et al.The Journal of Investigative Dermatology|March 1, 1981
Ultraviolet light depletes surface markers of Langerhans cellsW Aberer, G Schuler, G Stingl, et al.The Journal of Investigative Dermatology|July 1, 1980
Antigen presentation and allogeneic stimulation by Langerhans cellsI Green, G Stingl, E M Shevach, et al.Pageof 21